Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia
Bortezomib, a chemotherapeutic agent used in the treatment of hematologic malignancies, has been associated with multiple forms of lung injury including diffuse alveolar hemorrhage (DAH). We present the first reported case of bortezomib-induced DAH in a patient with plasma cell leukemia. This 59-yea...
Main Authors: | Ingrid M. Wirth, Gregory E. Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120303828 |
Similar Items
-
Diffuse alveolar hemorrhage, a rare presentation of polymyositis
by: Sharoon Samuel, et al.
Published: (2020-01-01) -
Diffuse alveolar hemorrhage in children with trisomy 21
by: Jessica L. Bloom, et al.
Published: (2021-07-01) -
Metastatic angiosarcoma presenting as diffuse alveolar hemorrhage
by: Rai S, et al.
Published: (2008-01-01) -
Diffuse alveolar hemorrhage
by: Deepa Panikkath, et al.
Published: (2015-01-01) -
A patient with diffuse alveolar hemorrhage: A diagnostic dilemma
by: Shahid A. Mohammed, et al.
Published: (2020-01-01)